Varenicline decreases alcohol consumption in heavy-drinking smokers
- Author(s): Fields, Howard
- Kayser, Andrew
- Mitchell, JM
- Teague, CH
- Kayser, AS
- Bartlett, SE
- Fields, HL
- et al.
Published Web Locationhttp://europepmc.org/articles/PMC3438402?pdf=render
Rationale Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor (nAChR) modulates the rewarding effects of alcohol. The nAChR α4β2 subunit partial agonist varenicline (ChantixTM), which is approved by the Food and Drug Admin
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.